Holding(s) In Company
Faron Pharmaceuticals Ltd has notified a major holding change due to the issue of treasury shares to the company, resulting in a new total holding of 25,000,000 shares, representing 10.97% of the voting rights, with the total number of voting rights held in the issuer being 227,881,315. This notification was made on June 11, 2026, following the event on the same date.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | June 11, 2026 at 17:05:00 EEST |
TR-1: Standard form for notification of major holdings
- Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
| Non-UK issuer | X |
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
| Other (please specify) iii : Issue of Treasury Shares to the Issuer | X |
Details of person subject to the notification obligation iv
| Name | Faron Pharmaceuticals Ltd |
| City and country of registered office (if applicable) | Turku, Finland |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 11.6.2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 11.6.2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 25,000,000 | 10.97% | 227,881,315 |
| Position of previous notification (if applicable) | |||
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| FI4000153309 | 25,000,000 | 10.97% | |
| SUBTOTAL 8. A | 25,000,000 | 10.97% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Faron Pharmaceuticals Ltd | 10.97% | 10.97% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
28.5.2026 Company announcement: Faron Pharmaceuticals Ltd: Issue of Treasury Shares to the Company
| Place of completion | Turku, Finland |
|---|---|
| Date of completion | 11.6.2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.